Vaccination centers using Aspaara software
Zurich - Aspaara has expanded the application area of its algorithm-based software for personnel planning to cover the needs of the vaccination campaign. Two vaccination centers have now become the first sites to use the software solution to coordinate shift plans.
Ava bracelet approved in the USA
Zurich - The United States Food and Drug Administration (FDA) has approved a bracelet developed by the MedTech firm Ava for the US market. This is the first and only wearable device that determines fertile days in women to have received FDA clearance.
Migros invests in Selma Finance
Zurich/Arth SZ - Sparrow Ventures, the venture capital arm of the Migros Group, has taken part in a financing round conducted by Selma Finance, a digital asset management firm based in the Greater Zurich Area. In addition, Migros Bank and the FinTech firm have agreed terms on a partnership.
Sevensense co-founder praises robotics scene in Switzerland
Zurich – Switzerland is fertile ground for robotics startups, says Roland Siegwart. The ETH Professor and co-founder of the startup Sevensense highlights the specialist expertise in precision mechanics and sensor technologies in the country.
Microlino successor model coming
Küsnacht ZH – The Microlino electric city car has been street legal across Europe since summer 2018. Now, Micro Mobility Systems AG is working on the successor model. The Microlino 2.0 boasts better handling characteristics, among other improvements.
Systemcredit secures new funding
Schlieren ZH – Systemcredit has raised a total of 400'000 Swiss francs in a funding round. The fintech brokers loans for SMEs on its platform. The funding will help it to expand its platform.
SEBA Bank makes cryptocurrency trading easier
Zug – Cryptocurrency specialist SEBA Bank has agreed a collaboration with ED&F Man Capital Markets. Traders will consequently benefit from a custody and margin payment solution.
First patient treated with Orpha Labs' drug
Baar ZG – This week, the first patient was treated in Israel with a drug developed by Orpha Labs to combat the rare disorder leukocyte adhesion deficiency type II (LAD II). In particularly serious cases, a special program can be used to grant patients access to this new, highly promising drug even before it has been officially authorized.
Helvetia invests in start-up Taxly
Zurich/St.Gallen - The Helvetia Venture Fund has invested in Taxly, a start-up active in the emerging field of TaxTech. Its software is designed to allow users to complete and file tax returns within a matter of minutes. Taxly is now keen to expand by offering its product beyond the cantons of Zurich, Aargau, St.Gallen and Basel-Landschaft.
Meet with an expansion expert
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line.